Here we show that the administration of Tat vaccine to mice infected with Mtb, the main coinfection of AIDS, was well-tolerated, immunogenic, did not abrogate the protective efficacy of BCG, the current TB vaccine, and, overall, reduced the lung immunopathology caused by Mtb. The gene discussed is TAT; the disease is AIDS.